Lojuxta - European Medicines Agency (EMA)
Lojuxta is a medicine that contains the active substance lomitapide. It is used to treat adult patients with homozygous familial hypercholesterolaemia, an inherited disease causing high …
Lomitapide - Wikipedia
Lomitapide, sold under the brand name Juxtapid in the US and Lojuxta in the EU, is a medication used as a lipid-lowering agent for the treatment of familial hypercholesterolemia, developed by …
Lojuxta is indicated as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis in adult patients with homozygous familial …
EMA：Aegerion高胆固醇血症新药Lojuxta获EMA批准-MedSci.cn
纯合子家族性高胆固醇血症 (HoFH)是一种极罕见的常染色体显性遗传性疾病，发病机制为细胞膜表面的低密度脂蛋白（LDL）受体缺如或异常，导致体内LDL代谢异常，造成血浆. 美国生物 …
Lojuxta is a medicine that contains the active substance lomitapide. It is used to treat adult patients with homozygous familial hypercholesterolaemia, an inherited disease causing high …
Lojuxta 20mg capsule（lomitapide 甲磺酸洛美他派硬胶囊）
Lojuxta是一种微粒体甘油三酯转移蛋白抑制剂适用于在有纯合子家族性高胆固醇血症(HoFH)患者作为对低脂肪膳食和其他降脂治疗，包括能得到LDL血液分离，辅助减低低密度脂蛋白胆固 …
甲磺酸洛美他派治疗同合子家族性高胆固醇血症 - 搜狐
2018年8月21日 · 2012年12月21日，美国食品与药物管理局（FDA）批准了洛美他派甲磺酸盐（lomitapide MESYLATE）上市，该药获准与低脂饮食和其他降脂药物一起用于治疗纯合性家 …
Lojuxta 5mg hard capsules - Summary of Product ... - medicines
Patients taking Lojuxta should avoid consumption of grapefruit juice. When administered with atorvastatin, the dose of Lojuxta should either be taken 12 hours apart or be decreased by half …
Lojuxta - Chiesi Farmaceutici SpA - 药物在线
Lojuxta is indicated as an adjunct to a low?fat diet and other lipid?lowering medicinal products with or without low-density-lipoprotein (LDL) apheresis in adult patients with homozygous …
Before prescribing Lojuxta, please refer to the full Summary of Product Characteristics (SmPC)i. Active Ingredient: Each hard capsule contains 5 mg, 10 mg or 20 mg lomitapide (as lomitapide …